SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04494776|
Recruitment Status : Recruiting
First Posted : July 31, 2020
Last Update Posted : July 31, 2020
|Condition or disease|
|SARS-CoV-2 Infection Kidney Transplant Infection|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Infection (COVID-19) in Kidney Transplant Recipients: a Brazilian Multicenter Study|
|Actual Study Start Date :||May 21, 2020|
|Estimated Primary Completion Date :||November 3, 2020|
|Estimated Study Completion Date :||April 2, 2022|
- Death [ Time Frame: Up to 3 months after resolution ]Death within 3 months after infection (Yes/No).
- Graft loss [ Time Frame: Up to 3 months after resolution ]Graft loss up to 3 months after infection (Yes/No).
- Hospitalization [ Time Frame: Until discharge date, an average of 1 month ]Composite outcomes: Mechanical ventilation (Yes/No); Need for dialysis (Yes/No); Need for ICU admission during evolution (Yes/No).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04494776
|Contact: Helio Tedesco||+55 11 firstname.lastname@example.org|
|Contact: Monica Nakamura||+55 11 5087 8318|
|Hospital do Rim||Recruiting|
|São Paulo, Aão Paulo, Brazil, 04038-002|
|Study Director:||Jose Osmar Medina||Hospital do Rim|